Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Name: Jazz Pharmaceuticals plc: Is Infosys Ltd. worth buying?
Item: Jazz Pharmaceuticals plc
Rating: 2.184305625
Author: Trendlyne DVM scores

Turnaround Potential

about

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

161.13 0.88 (0.55%)

68.74% Gain from 52W Low

1.2M

XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Jazz Pharma PLC is on 13 Jan 2026 for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details

Medium Financial Strength

38.9 / 100

Mid Valuation

35.7 / 100

Technically Moderately Bullish

61.3 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

217

1Yr Price target upside is 34%

16 analysts

Jazz Pharma PLC Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

68.74% Gain from 52W Low

SWOT Analysis

Jazz Pharma PLC Live Price Chart